Skip to main content
. 2016 Jun 22;16(3):255–261. doi: 10.1007/s40268-016-0137-9

Table 1.

Patient characteristics at baseline (N = 27)

N (%) or mean ± SD
Sex, men 17 (63.0)
Age, years 49.7 ± 8.8
Body mass index, kg/m2 32.7 ± 6.5
Oral hypoglycemic agents, yes 22 (81.5)
DPP-4 inhibitor 15 (55.6)
Sulfonylurea 5 (18.5)
Metformin 18 (66.7)
Thiazolidine 6 (22.2)
Insulin 8 (29.6)
GLP-1 receptor agonist 3 (11.1)

SD standard deviation, DPP-4 dipeptidyl peptidase 4, GLP-1 glucagon-like peptide-1